221 related articles for article (PubMed ID: 19362193)
1. High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats.
Singh AK; Chaurasiya A; Jain GK; Awasthi A; Asati D; Mishra G; Khar RK; Mukherjee R
Talanta; 2009 Jun; 78(4-5):1310-4. PubMed ID: 19362193
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects.
Lee S; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2010 Dec; 32(14):2496-501. PubMed ID: 21353117
[TBL] [Abstract][Full Text] [Related]
3. HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits.
Jing Q; Shen Y; Ren F; Chen J; Jiang Z; Peng B; Leng Y; Dong J
J Pharm Biomed Anal; 2006 Nov; 42(5):613-7. PubMed ID: 16824723
[TBL] [Abstract][Full Text] [Related]
4. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
[TBL] [Abstract][Full Text] [Related]
5. The relative bioavailability study and fasting and fed states pharmacokinetics of bicalutamide 50-mg tablets in healthy Chinese volunteers.
Lu HM; Ye M
Arzneimittelforschung; 2012 Jan; 62(1):18-21. PubMed ID: 22331758
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
7. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a highly sensitive LC-MS/MS-ESI method for the determination of bicalutamide in mouse plasma: application to a pharmacokinetic study.
Sharma K; Pawar GV; Giri S; Rajagopal S; Mullangi R
Biomed Chromatogr; 2012 Dec; 26(12):1589-95. PubMed ID: 22495777
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.
Lee S; Chung YJ; Kim BH; Shim JH; Yoon SH; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Dec; 31(12):3000-8. PubMed ID: 20110037
[TBL] [Abstract][Full Text] [Related]
10. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry.
Cui S; Zhao C; Tang X; Chen D; He Z
Biomed Chromatogr; 2005 Jun; 19(5):375-8. PubMed ID: 15627278
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
[TBL] [Abstract][Full Text] [Related]
12. A study of plasma bicalutamide concentrations in hemodialysis patients.
Ito F; Goya N; Nakazawa H; Suzuki T; Suzuki K; Kubo K; Kihara T
Urol Int; 2012; 89(2):162-5. PubMed ID: 22868217
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of two novel bicalutamide formulations in healthy male volunteers.
Cantarini M; Fuhr R; Morris T
Pharmacology; 2006; 77(4):171-8. PubMed ID: 16847400
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.
Wu W; Wang Y; Que L
Eur J Pharm Biopharm; 2006 Jul; 63(3):288-94. PubMed ID: 16527467
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
16. Bicalutamide nanocrystals with improved oral bioavailability: in vitro and in vivo evaluation.
Pokharkar VB; Malhi T; Mandpe L
Pharm Dev Technol; 2013; 18(3):660-6. PubMed ID: 22394215
[TBL] [Abstract][Full Text] [Related]
17. An improved and validated LC method for resolution of bicalutamide enantiomers using amylose tris-(3,5-dimethylphenylcarbamate) as a chiral stationary phase.
Nageswara Rao R; Narasa Raju A; Nagaraju D
J Pharm Biomed Anal; 2006 Sep; 42(3):347-53. PubMed ID: 16750608
[TBL] [Abstract][Full Text] [Related]
18. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Biopharm; 2008 Oct; 70(2):439-44. PubMed ID: 18603415
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
20. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
